TLR4 and atherosclerosis: To test the hypothesis, we used a CUMS model in apoE-/- mice to investigate the effects of TLR4 small interfering RNA (siRNA) and a specific NF-κB antagonist pyrrolidine dithiocarbamate (PDTC) on stress-induced inflammation and atherosclerosis.